Strs Ohio Replimune Group, Inc. Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 02, 2023	BUY	$17.48 - $29.09 $75,164 - $125,087	4,300 New	4,300 $75,000
Q3 2021 Oct 22, 2021	SELL	$28.98 - $39.54 $63,756 - $86,988	-2,200 Reduced 33.85%	4,300 $127,000
Q2 2021 Jul 26, 2021	BUY	$28.5 - $39.37 $17,100 - $23,622	600 Added 10.17%	6,500 $249,000
Q1 2021 Apr 23, 2021	SELL	$30.22 - $45.57 $24,176 - $36,456	-800 Reduced 11.94%	5,900 $180,000
Q4 2020 Jan 25, 2021	BUY	$23.5 - $52.65 $94,000 - $210,600	4,000 Added 148.15%	6,700 $255,000
Q2 2020 Jul 23, 2020	BUY	$9.76 - $25.95 $5,856 - $15,570	600 Added 28.57%	2,700 $67,000
Q3 2018 Oct 19, 2018	BUY	$14.99 - $22.14 $31,479 - $46,494	2,100 New	2,100 $33,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.